Literature DB >> 126838

Stimulation of chondroitin sulfate proteoglycan production by chondrocytes in monolayer.

N B Schwartz, A Dorfman.   

Abstract

Chondrocytes in monolayer undergo morphological and biochemical changes which culminate in the establishment of cartilage nodules in vitro. Chondroitin sulfate or heparin, added to the culture media of these cells, stimulates the production of chondroitin sulfate proteoglycan over the entire period of culture with a maximum effect during the log phase of growth. In addition, a lag of 2-3 hours is required before an increase in sulfate incorporation into polysaccharide is observed. The responsiveness of chondrocytes is influenced by several factors, such as cell density, conditioned media and enzyme treatment. Furthermore, puromycin abolishes the endogenous as well as the stimulated synthesis, demonstrating the necessity for core protein synthesis in both synthetic processes. Addition of beta-D-xylosides (which presumably act as initiators of chondroitin sulfate polysaccharide synthesis) and chondroitin sulfate, concurrently, stimulate sulfate incorporation to levels higher than either agent alone, indicating that these compounds act by different mechanisms.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 126838     DOI: 10.3109/03008207509152169

Source DB:  PubMed          Journal:  Connect Tissue Res        ISSN: 0300-8207            Impact factor:   3.417


  10 in total

1.  Collagen synthesis and deposition in cartilage during disrupted proteoglycan production.

Authors:  P Dondi; H Muir
Journal:  Biochem J       Date:  1976-10-15       Impact factor: 3.857

2.  Evaluation of the effect of antiarthritic drugs on the secretion of proteoglycans by lapine chondrocytes using a novel assay procedure.

Authors:  S Collier; P Ghosh
Journal:  Ann Rheum Dis       Date:  1989-05       Impact factor: 19.103

3.  Chondroitin sulfate in the treatment of osteoarthritis: from in vitro studies to clinical recommendations.

Authors:  Yves Henrotin; Mariane Mathy; Christelle Sanchez; Cecile Lambert
Journal:  Ther Adv Musculoskelet Dis       Date:  2010-12       Impact factor: 5.346

4.  Regionally disturbed production of cartilage proteoglycans in malformed fetuses from diabetic rats.

Authors:  E Unger; U J Eriksson
Journal:  Diabetologia       Date:  1992-06       Impact factor: 10.122

5.  The in vitro influence of different culture conditions on the potential of sheep rib perichondrium to form hyaline-like cartilage. Evaluation of gluing materials used for in vivo graft fixation.

Authors:  J Bruns; P Kersten; W Lierse; A Weiss; M Silbermann
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

6.  Four classes of cell-associated proteoglycans in suspension cultures of articular-cartilage chondrocytes.

Authors:  Y Sommarin; D Heinegård
Journal:  Biochem J       Date:  1986-02-01       Impact factor: 3.857

7.  Influence of chondroitin sulfate on the biochemical, mechanical and frictional properties of cartilage explants in long-term culture.

Authors:  Liming Bian; Michael Kaplun; David Y Williams; Duo Xu; Gerard A Ateshian; Clark T Hung
Journal:  J Biomech       Date:  2008-12-30       Impact factor: 2.712

8.  Optimized alkylated cyclodextrin polysulphates with reduced risks on thromboembolic accidents improve osteoarthritic chondrocyte metabolism.

Authors:  Sara Groeneboer; Stijn Lambrecht; Aad Dhollander; Peggy Jacques; Bert Vander Cruyssen; Rik J Lories; Katrien Devreese; Koen Chiers; Dirk Elewaut; Gust Verbruggen
Journal:  Rheumatology (Oxford)       Date:  2011-02-23       Impact factor: 7.580

9.  Effects of gangliosides from deer bone extract on the gene expressions of matrix metalloproteinases and collagen type II in interleukin-1β-induced osteoarthritic chondrocytes.

Authors:  Hyung Joo Suh; Hyunji Lee; Byung Jung Min; Sung Ug Jung; Eun Young Jung
Journal:  Nutr Res Pract       Date:  2016-08-31       Impact factor: 1.926

10.  Glucosamine and chondroitin sulfate supplementation to treat symptomatic disc degeneration: biochemical rationale and case report.

Authors:  Wim J van Blitterswijk; Jos C M van de Nes; Paul I J M Wuisman
Journal:  BMC Complement Altern Med       Date:  2003-06-10       Impact factor: 3.659

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.